HOME >> BIOLOGY >> NEWS
Leading scientists to discuss research applications for therapeutic cloning

PHILADELPHIA, Oct. 20 As members of the United Nations General Assembly are soon to vote on the future of cloning research, possibly within days, leading scientists will be conducting a symposium discussion on the status of current work in cloning and its potential for the emerging field of regenerative medicine.

Gerald Schatten, Ph.D., professor of obstetrics, gynecology and reproductive sciences and cell biology and physiology at the University of Pittsburgh School of Medicine, will join South Korean researchers Woo Suk Hwang, D.V.M., Ph.D., and Shin Yong Moon, M.D., in a panel discussion of scientific and ethical issues surrounding cloning research on Wednesday, Oct. 20, at the 60th annual meeting of the American Society for Reproductive Medicine. Scientific sessions will take place Oct. 16-20 at the Pennsylvania Convention Center in Philadelphia.

In February, Drs. Hwang and Moon from Seoul National University, reported the successful harvesting of human embryonic stem cells from a cloned embryo. The cloning symposium, called "Assisted Regenerative Medicine: The Future of ART?" and chaired by Linda Giudice, M.D., Ph.D., of Stanford University, will take place on Wednesday, Oct. 20.

"Human reproductive cloning is unsafe, unethical and ought to be illegal everywhere in the world," said Dr. Schatten, who also is director of the Pittsburgh Development Center at the Magee-Womens Research Institute. "But a ban on all forms of human cloning sends the wrong signal to the scientific community; it stigmatizes the research and will slow the pace of discoveries for decades to come."

Dr. Schatten, who testified before U.N. delegates on the issue in June, is close to the debate because he has been trying to clone primates, which belong to the same overall species classification as humans. The implications of any success for the prospects of human cloning are clear, and Dr. Schatten is exploring ways to make sure that if he succeeds, others wo
'"/>


20-Oct-2004


Page: 1 2 3

Related biology news :

1. Leading the fight against food poisoning
2. Leading researchers honored for progress in cancer prevention, detection and treatment
3. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
4. Leading cause of US food-borne illness makes its own pathway through cells
5. Leading scientists elected to EMBO ranks
6. Leading scientists gather to discuss developments in infectious disease research
7. Leading stem cell expert moves to UK
8. Leading breast cancer researcher awarded new lectureship
9. Leading experts confront global burden of chronic disease 8 Dec. at Abelson Science Seminar
10. Leading researchers from Israel and Southern California to present stem cell symposium
11. Leading experts present latest in cancer prevention research

Post Your Comments:
(Date:5/21/2013)... modifications, which alter the way genes function without ... detected in the blood of pregnant women during ... foretell depression in the weeks after giving birth, ... debilitating. , The findings of the small study ... the journal Molecular Psychiatry . , "Postpartum ...
(Date:5/20/2013)... New research suggests that a compound abundant in the ... death. , By altering a very specific step ... into normal cells that die as scheduled. , One ... process that would cause them to die on a ... study in cells, led by Ohio State University researchers, ...
(Date:5/19/2013)... novel study reports that white men and women of ... (hallux valgus) and lesser toe deformities, including hammer or ... to estimate the heritability of foot disorders in humansappear ... published by Wiley on behalf of the American College ... as many as 60% of older adults have foot ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3Blame your parents for bunion woes 2
(Date:5/21/2013)... May 21, 2013 As the ... strong push within the industry to deliver better ... Organizations and pharma companies often means turning big ... Microtablets, developed in collaboration with Sensidose AB and ... can bring products to market sooner. The partnership ...
(Date:5/21/2013)... 2013  MacroGenics, Inc. today announced that an ... an Fc-modified chimeric monoclonal antibody (MAb), in patients ... will be presented at the 2013 Annual Meeting ... the Developmental Therapeutics - Immunotherapy Oral Abstract Session ... PM.  The presentation will describe the results of ...
(Date:5/21/2013)... York, NY (PRWEB) May 21, 2013 Bed ... And according to My Cleaning Products, many turn to chemical-based ... because of the health and environmental risks those solutions present, ... with Bed Bug Bully instead. , According to ... bed bugs as they used to be. It shared that ...
(Date:5/21/2013)... Inflamax scientists worked closely with internationally ... the study, which will provide critical insight into ... in the study of allergy treatments, the Environmental ... models. Although both the models are well recognized ... direct comparison between the allergic responses evoked by ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: